ARCHIVES

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

This article is from The Cancer Letter archive.

Vol. 20 No. 15 | April 15, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

August 28, 1981

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000

Project Enlists PC Users In Quest For Cancer Drugs.

April 6, 2001